ReviewAdvances in therapy2026
Treating Severe Obesity: A Medical Perspective.
Review in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global prevalence of obesity has increased substantially over the past several decades, with the most rapid growth occurring among individuals at the highest levels of body mass index (BMI). Greater degrees of adiposity are associated with a disproportionately high burden of cardiometabolic disease, functional impairment, and healthcare utilization. Individuals with severe obesity exhibit distinct clinical characteristics that may influence disease risk, therapeutic response, and long-term outcomes. Clinician knowledge of unique attributes of this population and effective therapy is imperative for successful weight management and prevention of progression of metabolic burden. Optimizing outcomes frequently requires a multimodal treatment approach, and a clear understanding of how to effectively integrate these therapies is essential for successful management. Severe obesity as defined as BMI ≥ 50 kg/m
Indexed as
Identifiers
42334796What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.